This comprehensive analysis evaluates the quality parameters of Metformin 850mg tablets produced by Genfar. The assessment covers multiple aspects including chemical purity, concentration accuracy, and physical characteristics to ensure the medication meets pharmaceutical standards for diabetes treatment. Detailed analytical procedures were implemented to guarantee reliable results.

GC-MS and UV-Vis - Gas Chromatography-Mass Spectrometry for volatile compound analysis and identification, and UV-Visible Spectrophotometry for concentration determination through light absorption measurements.

The Metformin 850mg tablets demonstrate excellent quality characteristics with high purity levels and minimal detectable impurities. The analytical results confirm the product maintains consistent concentration within acceptable limits, ensuring reliable therapeutic performance for diabetes management. All tested parameters comply with international pharmacopeial standards.